Latest news with #DrNouraAlGhaithi
Gulf Business
10 hours ago
- Health
- Gulf Business
Future of weight loss: Inside Abu Dhabi's latest health programme
Image credit: WAM/ Website The Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC) have announced the launch of a first-of-its-kind Personalised Weight Management Programme in the region. Combining digital monitoring, a unique reimbursement model, and tailored clinical support, the initiative promotes sustainable weight management and active living. It aims to significantly reduce the risk of chronic diseases such as type 2 diabetes, heart disease, and certain cancers—ultimately enhancing quality of life and health longevity. Innovative model for long-term health impact The programme is open to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese. It features an innovative reimbursement model designed to encourage sustained engagement, personal accountability, and continuous participation. Read- 'Our focus is on health—not just weight. This programme supports our vision of an active, health-conscious community by empowering individuals through personalised, science-driven solutions. Weight management requires customised approaches, not a 'one-size-fits-all' model, and this programme ensures that each participant receives the support they need to succeed,' said Dr. Noura Al Ghaithi, Undersecretary of DoH. Bridging gaps in preventive healthcare 'We know that even modest weight loss and small increases in physical activity can significantly lower the risk of chronic disease. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming more physically active or in connecting them with relevant services. Our programme addresses this gap by providing structured guidance, personalised activity plans, and continuous monitoring through digital tools and clinical oversight—empowering our community to proactively manage their health and improve their quality of life,' said Dr. Rashid Obaid Al Suwaidi, Director-General of ADPHC.
Zawya
11 hours ago
- Health
- Zawya
Abu Dhabi launches unique personalised weight management programme to reduce chronic disease
ABU DHABI - The Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC) announced the launch of a new, first-of-its-kind in the region, Personalised Weight Management Programme. Integrating digital monitoring, a unique reimbursement model and tailored clinical support, this initiative promotes sustainable weight management and active living to significantly reduce the risks of chronic diseases such as type 2 diabetes, heart disease, and certain cancers, and ultimately, enhancing overall quality of life and health longevity. Open to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese, the programme features an innovative reimbursement model designed to encourage sustained engagement, accountability, and continuous active participation. Dr. Noura Al Ghaithi, Undersecretary of DoH, said, 'Our focus is on health – not just weight. This programme supports our vision for an active, health-conscious community, empowering individuals through personalised and science-driven solutions. Weight management requires tailored solutions, not a 'one-size-fits-all' approach, and this programme ensures each participant receives precisely what they need to succeed.' Dr. Rashid Obaid Al Suwaidi, Director-General of ADPHC, stated, 'We know that even moderate weight loss and modest increases in physical activity significantly lower chronic disease risk. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming physically active or to effectively link them with supportive services. Our programme directly addresses this gap by providing structured guidance, personalised activity plans, and continuous monitoring support through digital tools and clinical oversight - empowering our community to proactively manage their health and enhance their quality of life.'
Zawya
3 days ago
- Health
- Zawya
DoH and Boehringer Ingelheim Ink strategic partnership to advance life science innovation across the Emirate
Abu Dhabi, United Arab Emirates: The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world's leading research-driven pharmaceutical companies. This strategic partnership aims to advance scientific research and innovation, foster groundbreaking research and development and cultivate an environment of scientific excellence, further cementing the Emirate as the MENA region's premier hub for healthcare, life sciences and innovation. In the presence of H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Ousama Alhaj, General Manager and Head of Human Pharma, Near East and UAE at BI, the agreement was signed during BIO International Convention in Boston at the Abu Dhabi Pavilion by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Ghaleb Al Ahdab, Head of Public and Government Affairs, Near East and UAE at BI. Through this strategic partnership, the two parties seek to strengthen the Emirate's research ecosystem by facilitating access to and harnessing the capabilities of Boehringer Ingelheim'sOpnME platform. Researchers, scientists and innovators across Abu Dhabi will be able to leverage the platform's cutting-edge data and resources to address critical biological challenges and accelerate scientific discovery. Through four flagship programmes, Molecule to Order (M2O), Molecule for Collaboration (M4C), opn2EXPERTS (o2e) and opnTALENTS (o25), the platform empowers the research community with access to advanced compounds, collaborative opportunities, expert networks and support for emerging talent. OpnME connects visionary researchers to champion transformative, research-driven medical innovation for generations to come. In line with Abu Dhabi's vision to shape the future of healthcare, this partnership between DoH and BI enhances knowledge exchange and invests in local talent. It offers scientists a purpose-driven, globally connected environment to lead impactful research, further reinforcing the Emirate's commitment to transforming the regional healthcare ecosystem through science and technology. Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Health Life Sciences Sector at DoH, said: 'Our partnership with Boehringer Ingelheim reflects our commitment to pioneering innovation and scientific research as parts of our efforts to advance health outcomes and improve the quality of life for communities around the world. We're empowering Abu Dhabi researchers with the opnMe platform, an open portal offering top-tier pharmaceutical compounds, fostering collaboration and safeguarding researchers' rights to their findings. This is about transforming our emirate into a global life sciences hub, speeding up breakthroughs, and building a healthier, resilient future for all.' Ousama Alhaj, General Manager and Head of Human Pharma for Near East and UAE at Boehringer Ingelheim, said: 'At Boehringer Ingelheim, we are proud to partner with the Department of Health – Abu Dhabi (DoH) to empower the scientific community through our OpnMe platform. This collaboration reflects our shared commitment to advancing research and innovation in the region, fostering a culture of discovery, and ultimately improving patient outcomes. By providing access to our scientific resources, including advanced compounds, collaborative research opportunities, and expert networks, we aim to inspire new ideas and support the next generation of researchers in Abu Dhabi.' Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 14 to 21, delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual.
